Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon Lan

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Clinical Trials (London, England)|July 22, 2015
Sample size adjustment based on promising interim results and its application in confirmatory clinical trialsY H Joshua Chen, Caiyan Li, K K Gordon Lan
Journal of Biopharmaceutical Statistics|June 23, 2004
Conditional bias of point estimates following a group sequential testXiaoyin Frank Fan, David L DeMets, K K Gordon Lan
Journal of Biopharmaceutical Statistics|September 6, 2012
Design and sample size considerations for simultaneous global drug development programQin Huang, Gang Chen, Zhilong Yuan, et al.
Statistics in Medicine|July 27, 2010
Some drop-the-loser designs for monitoring multiple dosesY H Joshua Chen, David L Demets, K K Gordon Lan
Controlled Clinical Trials|February 1, 2003
Monitoring mortality at interim analyses while testing a composite endpoint at the final analysisY H Joshua Chen, David L DeMets, K K Gordon Lan
Statistics in Medicine|April 2, 2004
Increasing the sample size when the unblinded interim result is promisingY H Joshua Chen, David L DeMets, K K Gordon Lan
Statistics in Biopharmaceutical Research|April 24, 2025
Monitoring Ongoing Clinical Trials under Fractional Brownian Motion with DriftPeng Zhang, Weichung Joe Shih, Yong Lin, et al.
Statistics in Medicine|February 3, 2016
Assessing the consistency of the treatment effect under the discrete random effects model in multiregional clinical trialsJung-Tzu Liu, Hsiao-Hui Tsou, K K Gordon Lan, et al.
Pharmaceutical Statistics|June 23, 2010
Proposals of statistical consideration to evaluation of results for a specific region in multi-regional trials--Asian perspectiveHsiao-Hui Tsou, Shein-Chung Chow, K K Gordon Lan, et al.
Therapeutic Innovation & Regulatory Science|February 3, 2020
Lessons Learned From Multi-regional Trials With Signals of Treatment Effect HeterogeneityGang Li, Hui Quan, Gordon Lan, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical Trials (London, England)|July 22, 2015
Sample size adjustment based on promising interim results and its application in confirmatory clinical trialsY H Joshua Chen, Caiyan Li, K K Gordon Lan
Journal of Biopharmaceutical Statistics|June 23, 2004
Conditional bias of point estimates following a group sequential testXiaoyin Frank Fan, David L DeMets, K K Gordon Lan
Journal of Biopharmaceutical Statistics|September 6, 2012
Design and sample size considerations for simultaneous global drug development programQin Huang, Gang Chen, Zhilong Yuan, et al.
Statistics in Medicine|July 27, 2010
Some drop-the-loser designs for monitoring multiple dosesY H Joshua Chen, David L Demets, K K Gordon Lan
Controlled Clinical Trials|February 1, 2003
Monitoring mortality at interim analyses while testing a composite endpoint at the final analysisY H Joshua Chen, David L DeMets, K K Gordon Lan
Statistics in Medicine|April 2, 2004
Increasing the sample size when the unblinded interim result is promisingY H Joshua Chen, David L DeMets, K K Gordon Lan
Statistics in Biopharmaceutical Research|April 24, 2025
Monitoring Ongoing Clinical Trials under Fractional Brownian Motion with DriftPeng Zhang, Weichung Joe Shih, Yong Lin, et al.
Statistics in Medicine|February 3, 2016
Assessing the consistency of the treatment effect under the discrete random effects model in multiregional clinical trialsJung-Tzu Liu, Hsiao-Hui Tsou, K K Gordon Lan, et al.
Pharmaceutical Statistics|June 23, 2010
Proposals of statistical consideration to evaluation of results for a specific region in multi-regional trials--Asian perspectiveHsiao-Hui Tsou, Shein-Chung Chow, K K Gordon Lan, et al.
Therapeutic Innovation & Regulatory Science|February 3, 2020
Lessons Learned From Multi-regional Trials With Signals of Treatment Effect HeterogeneityGang Li, Hui Quan, Gordon Lan, et al.
Pageof 2